Tech4Eva Opening Ceremony 2022

Lan is the Deputy Managing Director of EPFL Innovation Park and an Expert of Innosuisse – the Swiss Innovation Agency.  She has 23 years of hands-on professional experience in industry as well as in the ecosystem of innovation & entrepreneurship.

Lan started her career at R&D department of Rolex, in charge of creating new computer aided design and optimisation tools in the product development process. She was later appointed as Head of Operational Planning at Pictet, working closely with a startup to design, develop and implement a management information system for group operation control. As the Managing Director of Geneva Creativity Center, she connected large corporations, SMEs, startups and researchers to initiate innovative joint R&D projects.

Currently at EPFL Innovation Park, she is leading entrepreneurship training and acceleration programs and is helping startups to establish business partnership with large corporations. Lan has a PhD degree from EPFL, an MBA from HEC Lausanne and postdoctoral applied research experience at Stanford University.

Dr. Jill M. Goldstein is a Professor of Psychiatry and Medicine at Harvard Medical School, Founder and Executive Director of the Innovation Center on Sex Differences in Medicine (ICON; http://icon.mgh.harvard.edu), and the Helen T. Moerschner Endowed Research Institute Chair in Women’s Health at Massachusetts General Hospital.

Her program of research, called the Clinical Neuroscience Laboratory of Sex Differences in the Brain (CNL; http://cnl-sd.mgh.harvard.edu) consists of an interdisciplinary team of investigators, integrating structural and functional brain imaging with psychophysiology, neuroendocrinology, immunology, and genetics, and collaborative efforts with basic neuroscientists studying genes, hormones, immune function, and the brain. Primary brain circuitries under investigation include the stress response and mood/anxiety circuitries, memory/working memory, and reward circuitry. Sex differences in disorders of interest include major depressive disorder and its comorbidity with cardiometabolic diseases, psychoses, and brain aging and risk for Alzheimer’s disease. This work has been funded by the National Institutes of Health for >30 years. She has published >200 articles, chapters and other original and peer-reviewed work in these areas.

Dr. Goldstein is also an administrative and educational leader in women’s health and sex differences in medicine, locally, nationally and globally. She serves on several scientific advisory boards and participated in strategic planning for the National Institute of Mental Health, NIH Office of Research on Women’s Health (ORWH), the Institute of Medicine, and the Brain Health Initiative for Us Against Alzheimers. Dr. Goldstein is also a leader in training the next generation of women and men in women’s health and sex differences in medicine, leading an NIH ORWH training program for junior faculty for >17 years.

In 2018, she launched the Innovation Center on Sex Differences in Medicine (ICON) whose mission is to enhance discoveries on sex differences in medicine and translate them into the development of sex-dependent therapeutics to address the need for precision medicine. The first public health challenge of ICON is to develop sex-dependent therapies targeted to the neural-cardiac interface to address sex differences in the substantially high comorbidity (particularly in women) of depression, cardiovascular disease, and Alzheimer’s disease. In 2020, ICON was designated with substantial funding an NIH Specialized Center of Research Excellence in Sex Differences, one of only 11 in the U.S.

To Read More About Dr. Goldstein’s research:

Innovation Center on Sex Differences in Medicine:  http://icon.mgh.harvard.edu

Clinical Neuroscience Laboratory of Sex Differences in the Brain: http://cnl-sd.mgh.harvard.edu

Ted Talk: “When it comes to heart and brain disorders, sex matters”  https://www.tedmed.com/talks/show?id=691322

Visit website http://icon.mgh.harvard.edu

‍

COO of Groupe Mutuel since 2013, Sophie Revazis Director of the "Individual services" area, which brings together more than 1,000 employees, more than 65% of whom are women.  These departments are at the heart of insurance since they are dedicated to contract management, reimbursement of benefits, price negotiations and payment traffic& litigation.  A lawyer by training, Sophie Revaz was previously in charge of the legal part and human resources.  She is also a member of the Swiss Circle of Directors.

‍

Ursula joined the EPFL as Vice President for Innovation on March 1st, 2021.

Prior to that, Ursula spent 20 years in Silicon Valley and Asia working in open innovation and with start-ups. First, she worked in the telecom-IT industry and then in Life Science. She led digital innovation initiatives and corporate transformation programs. She holds a PhD in physics from EPFL.

‍

Usha Sarma is the Research Strategy Manager of the ARTORG Center for Biomedical Engineering Research and the Center for AI in Medicine at the University of Bern.

She has spent two decades supporting the discovery, development and transfer of life science, medical and clinical research from academia into the clinic and the marketplace in the U.K., Germany and Switzerland. She has led translation and private equity investment activities into successful new ventures in diagnostics, therapeutics and medical technology.

Usha holds a PhD in Immunology from Imperial College London and an MBA with a focus on Science Entrepreneurship from Bayes Business School, City University London.

‍

Marco is Entrepreneur, Coach and Trainer in the Swiss Start-up ecosystem with 20+ years international experience in strategic and operational roles across the LifeScience Industry and Healthcare Management.

He is a strong believer in well-balanced teams: motivated to challenge the status quo!

Passionate to work with the next generation of Entrepreneurs/Managers for the challenges of tomorrow. He focused on Start-up and Innovation Management, Translational medicine. His motto is “From idea to market”.

He holds a Medical Doctor from the University of Fribourg, Berne and Zurich, an Executive Masters in Medical Management from eMMM PHW Bern, and an Executive Masters in Business Administration from eMBA PHW Bern.

‍

Andrew is a strategic healthcare leader who has led innovative business development in pharmaceutical, consumer healthcare, and medical device businesses across East and West Europe, the Middle East and Africa, in former roles as Managing Director Pfizer Consumer Healthcare, Rohto Mentholatum, Bausch and Lomb, Allergan and Boots.

‍

Marten is a passionate and empathetic, a strategic thinker who cares deeply about relationships, both personal and professional. With his background in machine engineering, project management and product development he is now working for 2 years in the digital health industry leading a team of 4 to build a cutting edge digital support technology for emotions that will have a huge impact on people’s life.

‍